Preparation and biological profile of 99mTc-lidocaine as a cardioselective imaging agent using 99mTc eluted from 99Mo/99mTc generator based on Al–Mo gel

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Nature

Series Info

Journal of Radioanalytical and Nuclear Chemistry ; Volume 314 , Issue 3 , pages 2091–2098 , (2017)

Orcid

Abstract

The current study is aimed to prepare 99mTc-lidocaine as a new myocardial perfusion-imaging agent. The used 99mTc was obtained from Al–99Mo-molybdate(VI) gel matrix. 99mTc-lidocaine showed higher (15.4 ± 0.11% ID/g) and faster (15 min post injection) cardiac uptake than the recently studied 99mTc-valsartan and 99mTc-procainamide. Consequently, 99mTc-lidocaine will be a valuable myocardial SPECT agent for diagnosis of emergency patients. Besides, the receptor affinity study confirmed the selectivity of 99mTc-lidocaine for sodium channels in the heart.

Description

SJR 2025 0.354 Q3 H-Index 81 Subject Area and Category: Chemistry Analytical Chemistry Spectroscopy Energy Nuclear Energy and Engineering Environmental Science Health, Toxicology and Mutagenesis Pollution Medicine Public Health, Environmental and Occupational Health Radiology, Nuclear Medicine and Imaging

Citation

Sakr, T. M., Ibrahim, A. B., Fasih, T. W., & Rashed, H. M. (2017). Preparation and biological profile of 99mTc-lidocaine as a cardioselective imaging agent using 99mTc eluted from 99Mo/99mTc generator based on Al–Mo gel. Journal of Radioanalytical and Nuclear Chemistry, 314(3), 2091–2098. https://doi.org/10.1007/s10967-017-5560-z ‌

Endorsement

Review

Supplemented By

Referenced By